Research programme: G protein-coupled receptor modulators - Infinity Pharmaceuticals/AbbVie
Alternative Names: GPCR modulators - Infinity Pharmaceuticals/AllerganLatest Information Update: 19 May 2020
At a glance
- Originator Allergan; Infinity Pharmaceuticals
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Eye disorders; Neurological disorders
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 18 Jul 2007 Discontinued - Preclinical for Eye disorders in USA (unspecified route)
- 18 Jul 2007 Discontinued - Preclinical for Neurological disorders in USA (unspecified route)